291.20
-7.60
(-2.54%)
At close: 3:19:48 PM GMT+3
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
10,558,075.42
9,508,438.77
8,310,738.51
7,250,472.19
5,861,604.64
Cost of Revenue
6,942,466.56
6,238,390.70
5,562,603.30
4,920,242.73
3,997,193.53
Gross Profit
3,615,608.86
3,270,048.07
2,748,135.22
2,330,229.46
1,864,411.10
Operating Expense
1,335,507.54
1,160,608.65
1,036,109.86
853,381.61
743,913.86
Operating Income
2,280,101.31
2,109,439.42
1,712,025.36
1,476,847.85
1,120,497.24
Net Non Operating Interest Income Expense
-38,531.98
-1,766.47
-20,176.26
-38,689.45
-41,083.82
Pretax Income
2,305,355.06
2,169,986.91
1,796,657.10
1,501,343.68
1,127,801.60
Tax Provision
22,235.98
68,516.33
107,707.93
114,066.32
92,787.90
Net Income Common Stockholders
2,226,527.31
2,046,013.92
1,650,750.05
1,376,615.20
1,055,482.32
Diluted NI Available to Com Stockholders
2,226,527.31
2,046,013.92
1,650,750.05
1,376,615.20
1,055,482.32
Basic EPS
6.36
5.85
4.72
3.93
3.02
Diluted EPS
6.36
5.85
4.72
3.93
3.02
Basic Average Shares
350,000.00
350,000.00
350,000.00
350,000.00
350,000.00
Diluted Average Shares
350,000.00
350,000.00
350,000.00
350,000.00
350,000.00
Total Operating Income as Reported
2,266,310.81
2,095,648.92
1,700,487.33
1,466,151.27
1,114,856.49
Rent Expense Supplemental
--
12,458.18
10,126.44
7,812.20
7,089.26
Total Expenses
8,277,974.11
7,398,999.35
6,598,713.16
5,773,624.34
4,741,107.40
Net Income from Continuing & Discontinued Operation
2,226,527.31
2,046,013.92
1,650,750.05
1,376,615.20
1,055,482.32
Normalized Income
2,226,527.31
2,046,013.92
1,650,750.05
1,376,615.20
1,055,482.32
Interest Income
--
82,130.66
40,718.51
9,903.14
13,051.96
Interest Expense
106,872.14
70,106.62
49,356.75
37,896.01
48,495.02
Net Interest Income
-38,531.98
-1,766.47
-20,176.26
-38,689.45
-41,083.82
EBIT
2,412,227.20
2,240,093.53
1,846,013.85
1,539,239.69
1,176,296.62
EBITDA
2,778,091.02
2,552,772.03
2,155,236.66
1,854,033.20
1,494,119.62
Reconciled Cost of Revenue
6,942,466.56
6,238,390.70
5,562,603.30
4,920,242.73
3,997,193.53
Reconciled Depreciation
365,863.82
312,678.50
309,222.81
314,793.51
317,823.00
Net Income from Continuing Operation Net Minority Interest
2,226,527.31
2,046,013.92
1,650,750.05
1,376,615.20
1,055,482.32
Normalized EBITDA
2,778,091.02
2,552,772.03
2,155,236.66
1,854,033.20
1,494,119.62
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 3/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4017.SR Dr. Soliman Abdel Kader Fakeeh
68.90
+0.15%
4018.SR Almoosa Health Company
140.80
-0.71%
4002.SR Mouwasat Medical Services Company
91.80
+0.88%
4009.SR Middle East Healthcare Company
74.90
+0.54%
4007.SR Al Hammadi Holding Company
41.70
0.00%
4005.SR National Medical Care Company
158.00
-1.13%
4004.SR Dallah Healthcare Company
155.60
-0.13%
9530.SR Arabian International Healthcare Holding Company
38.90
-0.26%
MAXHEALTH.NS Max Healthcare Institute Limited
1,049.95
+1.05%
OPCH Option Care Health, Inc.
29.32
+1.95%